Theravance Biopharma (TBPH) Short Interest Ratio & Short Volume

$8.01

-0.20 (-2.44%)

(As of 04:30 PM ET)

Theravance Biopharma Short Interest Data

Theravance Biopharma (TBPH) has a short interest of 5.43 million shares, representing 12.06% of the float (the number of shares available for trading by the public). This marks a -2.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.6, indicating that it would take 13.6 days of the average trading volume of 382,718 shares to cover all short positions.

Current Short Interest: 5,430,000 shares
Previous Short Interest: 5,570,000 shares
Change Vs. Previous Month: -2.51%
Dollar Volume Sold Short: $44.80 million
Short Interest Ratio: 13.6 Days to Cover
Last Record Date: August 31, 2024

Outstanding Shares: 48,920,000 shares
Float Size: 45,010,000 shares
Short Percent of Float: 12.06%
Today's Trading Volume: 623,396 shares
Average Trading Volume: 382,718 shares
Today's Volume Vs. Average: 163%

Short Selling Theravance Biopharma?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Theravance Biopharma and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

TBPH Short Interest Over Time

TBPH Days to Cover Over Time

TBPH Percentage of Float Shorted Over Time

Ad Unstoppable Prosperity

Must-Know for Trading Options

Options are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must.

So make sure you claim your free seat by clicking here now.

Theravance Biopharma Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/31/2024	5,430,000 shares	$44.80 million	-2.5%	12.1%	13.6	$8.25
8/15/2024	5,570,000 shares	$45.95 million	+2.0%	12.4%	13.4	$8.25
7/31/2024	5,460,000 shares	$55.20 million	-3.2%	12.2%	12.9	$10.11
7/15/2024	5,640,000 shares	$55.67 million	-3.8%	12.6%	14.8	$9.87
6/30/2024	5,860,000 shares	$49.69 million	-6.8%	13.1%	15.3	$8.48
6/15/2024	6,290,000 shares	$53.34 million	+4.7%	14.1%	16.4	$8.48
Get the Latest News and Ratings for TBPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter.
5/31/2024	6,010,000 shares	$51.81 million	+2.0%	14.8%	15.2	$8.62
5/15/2024	5,890,000 shares	$58.02 million	-4.4%	13.4%	14.8	$9.85
4/30/2024	6,160,000 shares	$51.99 million	-4.2%	14.1%	15.3	$8.44
4/15/2024	6,430,000 shares	$63.79 million	-14.5%	14.7%	17.5	$9.92
3/31/2024	7,520,000 shares	$67.45 million	-10.5%	17.2%	20.3	$8.97
3/15/2024	8,400,000 shares	$72.58 million	-2.4%	18.9%	23.1	$8.64
2/29/2024	8,610,000 shares	$81.54 million	-2.8%	19.4%	22.7	$9.47
2/15/2024	8,860,000 shares	$76.82 million	+6.2%	19.3%	22.6	$8.67
1/31/2024	8,340,000 shares	$79.06 million	-2.3%	18.2%	20.4	$9.48
1/15/2024	8,540,000 shares	$83.95 million	-4.2%	18.6%	20.8	$9.83
12/31/2023	8,910,000 shares	$100.15 million	-4.4%	19.4%	21.5	$11.24
12/15/2023	9,320,000 shares	$102.43 million	-0.1%	20.3%	23.2	$10.99
11/30/2023	9,330,000 shares	$97.78 million	+2.8%	20.2%	21.8	$10.48
11/15/2023	9,080,000 shares	$92.89 million	+1.3%	19.7%	21.5	$10.23
10/31/2023	8,960,000 shares	$84.58 million	-0.4%	18.3%	20.4	$9.44
10/15/2023	9,000,000 shares	$81.54 million	+1.9%	18.4%	21	$9.06
9/30/2023	8,830,000 shares	$76.20 million	-2.7%	19.7%	20.4	$8.63
9/15/2023	9,070,000 shares	$81.63 million	+0.8%	20.3%	19.8	$9.00
8/31/2023	9,000,000 shares	$85.68 million	No Change	19.8%	19.4	$9.52
8/15/2023	9,000,000 shares	$91.26 million	+8.2%	19.8%	18.6	$10.14
7/31/2023	8,320,000 shares	$82.28 million	+1.0%	16.7%	16.2	$9.89
7/15/2023	8,240,000 shares	$80.67 million	+0.2%	16.6%	15.4	$9.79
6/30/2023	8,220,000 shares	$85.08 million	-6.2%	16.5%	14.3	$10.35
6/15/2023	8,760,000 shares	$91.02 million	+0.2%	17.6%	14.7	$10.39
5/31/2023	8,740,000 shares	$97.71 million	+3.2%	17.4%	16	$11.18
5/15/2023	8,470,000 shares	$95.37 million	+9.2%	16.9%	14.9	$11.26
4/30/2023	7,760,000 shares	$84.04 million	+1.8%	14.2%	14.8	$10.83
4/15/2023	7,620,000 shares	$90.83 million	+5.5%	14.0%	15.3	$11.92
3/31/2023	7,220,000 shares	$78.34 million	-4.9%	13.1%	14.2	$10.85
3/15/2023	7,590,000 shares	$80.15 million	-6.4%	14.1%	15.8	$10.56
2/28/2023	8,110,000 shares	$87.59 million	-5.0%	15.1%	16.9	$10.80
2/15/2023	8,540,000 shares	$88.13 million	-3.5%	14.7%	17.4	$10.32
1/31/2023	8,850,000 shares	$95.67 million	+2.1%	15.2%	13.7	$10.81
1/15/2023	8,670,000 shares	$97.97 million	+3.6%	14.8%	12.5	$11.30
Must-Know for Trading Options (Ad) Options are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must. So make sure you claim your free seat by clicking here now.
12/30/2022	8,370,000 shares	$93.91 million	+1.7%	14.3%	11.5	$11.22
12/15/2022	8,230,000 shares	$89.05 million	+3.4%	14.0%	10.7	$10.82
11/30/2022	7,960,000 shares	$85.65 million	+3.1%	13.6%	10.2	$10.76
11/15/2022	7,720,000 shares	$87.47 million	+3.6%	13.3%	10.1	$11.33
10/31/2022	7,450,000 shares	$74.28 million	-1.2%	12.9%	11.3	$9.97
10/15/2022	7,540,000 shares	$74.80 million	-2.3%	13.0%	12.4	$9.92
9/30/2022	7,720,000 shares	$78.28 million	+2.9%	N/A	7.6	$10.14
9/15/2022	7,500,000 shares	$75.38 million	-3.0%	N/A	7.9	$10.05
8/31/2022	7,730,000 shares	$69.65 million	No Change	13.9%	8.6	$9.01
8/15/2022	7,730,000 shares	$74.98 million	+3.5%	13.9%	8.4	$9.70
7/31/2022	7,470,000 shares	$65.66 million	-0.8%	14.0%	8	$8.79
7/15/2022	7,530,000 shares	$66.04 million	+1.6%	14.1%	8	$8.77
6/30/2022	7,410,000 shares	$67.13 million	-5.2%	13.8%	14.8	$9.06
6/15/2022	7,820,000 shares	$69.68 million	+0.3%	14.6%	15.1	$8.91
5/31/2022	7,800,000 shares	$68.48 million	-3.9%	14.6%	12.8	$8.78
5/15/2022	8,120,000 shares	$74.05 million	+5.9%	15.2%	11.5	$9.12
4/30/2022	7,670,000 shares	$74.02 million	+0.3%	15.2%	10	$9.65
4/15/2022	7,650,000 shares	$75.96 million	-6.8%	14.0%	9.2	$9.93
3/31/2022	8,210,000 shares	$78.49 million	+59.1%	15.2%	7.1	$9.56
3/15/2022	5,160,000 shares	$47.73 million	-26.7%	9.7%	3.9	$9.25
2/28/2022	7,040,000 shares	$70.89 million	-3.8%	13.2%	5	$10.07
2/15/2022	7,320,000 shares	$72.91 million	+23.7%	13.9%	5.2	$9.96
1/31/2022	5,920,000 shares	$53.93 million	+38.3%	9.5%	4.6	$9.11
1/15/2022	4,280,000 shares	$42.29 million	+17.3%	6.9%	3.5	$9.88
12/31/2021	3,650,000 shares	$40.33 million	+9.3%	6.9%	3.8	$11.05
12/15/2021	3,340,000 shares	$35.77 million	-18.7%	6.3%	4	$10.71
11/30/2021	4,110,000 shares	$34.52 million	+2.2%	7.7%	4.1	$8.40
11/15/2021	4,020,000 shares	$33.04 million	-5.4%	7.5%	3.4	$8.22
10/29/2021	4,250,000 shares	$33.02 million	+7.3%	7.8%	3.1	$7.77
10/15/2021	3,960,000 shares	$31.64 million	+26.1%	7.2%	3	$7.99
9/30/2021	3,140,000 shares	$23.24 million	+35.3%	5.7%	2.5	$7.40
9/15/2021	2,320,000 shares	$15.71 million	+10.5%	4.2%	1.8	$6.77
8/31/2021	2,100,000 shares	$17.43 million	-19.5%	3.8%	2.4	$8.30
8/13/2021	2,610,000 shares	$35.29 million	-3.7%	4.8%	6.1	$13.52
7/30/2021	2,710,000 shares	$35.18 million	-6.9%	5.2%	7	$12.98
7/15/2021	2,910,000 shares	$39.63 million	-1.4%	5.0%	8.4	$13.62
6/30/2021	2,950,000 shares	$42.83 million	-13.0%	5.2%	8.2	$14.52
6/15/2021	3,390,000 shares	$61.05 million	+2.1%	6.6%	11.9	$18.01
5/28/2021	3,320,000 shares	$57.37 million	-0.6%	6.5%	11.7	$17.28
5/14/2021	3,340,000 shares	$62.52 million	-9.7%	6.6%	10.5	$18.72
4/30/2021	3,700,000 shares	$73.41 million	-0.3%	7.3%	11.2	$19.84
4/15/2021	3,710,000 shares	$79.02 million	+6.0%	7.3%	10.8	$21.30
3/31/2021	3,500,000 shares	$72.24 million	-3.1%	6.9%	10.1	$20.64
3/15/2021	3,610,000 shares	$74.51 million	+2.6%	7.1%	10.6	$20.64
2/26/2021	3,520,000 shares	$60.93 million	+4.1%	7.1%	10.4	$17.31
2/12/2021	3,380,000 shares	$67.43 million	-0.6%	6.9%	10.1	$19.95
1/29/2021	3,400,000 shares	$62.25 million	+0.9%	6.8%	10.4	$18.31
1/15/2021	3,370,000 shares	$60.73 million	-6.4%	6.8%	9.7	$18.02
12/31/2020	3,600,000 shares	$63.58 million	-4.8%	7.2%	10.6	$17.66
12/15/2020	3,780,000 shares	$71.97 million	+8.6%	7.6%	10.4	$19.04
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on retiring any time soon... Every retirement dollar you have invested in paper assets will only continue to drop in value. We just released a Free Guide that reveals all the details. Click here to get the free Gold Guide now.
11/30/2020	3,480,000 shares	$57.11 million	-1.7%	7.0%	9.3	$16.41
11/15/2020	3,540,000 shares	$62.52 million	+0.3%	7.1%	9.4	$17.66
10/30/2020	3,530,000 shares	$68.02 million	+9.0%	7.1%	9.4	$19.27
10/15/2020	3,240,000 shares	$61.37 million	+7.3%	6.6%	9.2	$18.94
9/30/2020	3,020,000 shares	$44.65 million	-1.0%	6.1%	8.3	$14.79
9/15/2020	3,050,000 shares	$54.38 million	+6.3%	6.2%	8.1	$17.83
8/31/2020	2,870,000 shares	$52.61 million	+5.5%	5.8%	6.5	$18.33
8/14/2020	2,720,000 shares	$45.42 million	-8.4%	5.5%	5.7	$16.70
7/31/2020	2,970,000 shares	$57.68 million	+11.7%	6.1%	6.5	$19.42
7/15/2020	2,660,000 shares	$56.47 million	-22.0%	5.4%	5.8	$21.23
6/30/2020	3,410,000 shares	$70.38 million	+57.9%	7.0%	7.5	$20.64
6/15/2020	2,160,000 shares	$54.54 million	+8.5%	5.0%	5.2	$25.25
5/29/2020	1,990,000 shares	$50.25 million	-27.4%	4.6%	5.3	$25.25
5/15/2020	2,740,000 shares	$75.10 million	-3.2%	6.3%	7.7	$27.41
4/30/2020	2,830,000 shares	$82.52 million	-0.7%	6.5%	6.2	$29.16
4/15/2020	2,850,000 shares	$73.84 million	-6.3%	6.5%	6.1	$25.91
3/31/2020	3,040,000 shares	$92.05 million	-6.4%	7.0%	6.7	$30.28
3/13/2020	3,246,000 shares	$80.18 million	-3.7%	7.7%	8.3	$24.70
2/28/2020	3,370,000 shares	$75.69 million	+6.0%	8.0%	8.1	$22.46
2/14/2020	3,180,000 shares	$82.65 million	+10.0%	7.5%	7.7	$25.99
1/31/2020	2,890,000 shares	$68.70 million	+8.7%	7.8%	9.4	$23.77
1/15/2020	2,660,000 shares	$74.19 million	+0.8%	7.0%	9.1	$27.89
12/31/2019	2,640,000 shares	$68.96 million	-5.4%	6.9%	8.6	$26.12

TBPH Short Interest - Frequently Asked Questions

What is Theravance Biopharma's current short interest?: Short interest is the volume of Theravance Biopharma shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 5,430,000 shares of TBPH short. 12.06% of Theravance Biopharma's shares are currently sold short. Learn More on Theravance Biopharma's current short interest.
What is a good short interest ratio for Theravance Biopharma?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TBPH shares currently have a short interest ratio of 14.0. Learn More on Theravance Biopharma's short interest ratio.
What is a good short interest percentage for Theravance Biopharma?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.06% of Theravance Biopharma's floating shares are currently sold short.
Is Theravance Biopharma's short interest increasing or decreasing?: Theravance Biopharma saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 5,430,000 shares, a decrease of 2.5% from the previous total of 5,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is Theravance Biopharma's float size?: Theravance Biopharma currently has issued a total of 48,920,000 shares. Some of Theravance Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Theravance Biopharma currently has a public float of 45,010,000 shares.

How does Theravance Biopharma's short interest compare to its competitors?: 12.06% of Theravance Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Theravance Biopharma: Annexon, Inc. (7.62%), Pliant Therapeutics, Inc. (12.06%), Harrow, Inc. (11.56%), Kura Oncology, Inc. (16.65%), Syndax Pharmaceuticals, Inc. (11.15%), Arcus Biosciences, Inc. (13.83%), Cassava Sciences, Inc. (32.95%), Dynavax Technologies Co. (13.98%), Ardelyx, Inc. (10.68%), Schrödinger, Inc. (11.99%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.
What does it mean to sell short Theravance Biopharma stock?: Short selling TBPH is an investing strategy that aims to generate trading profit from Theravance Biopharma as its price is falling. TBPH shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Theravance Biopharma?: A short squeeze for Theravance Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TBPH, which in turn drives the price of the stock up even further.
How often is Theravance Biopharma's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TBPH, twice per month. The most recent reporting period available is August, 31 2024.